You have 9 free searches left this month | for more free features.

Condition

Myeloproliferative Neoplasms (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Incyte Corporation (2)

Collaborator

Intervention

inca033989 (2)

ruxolitinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

inca033989

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Myeloproliferative Tumors Trial (INCA033989)

Not yet recruiting

Myeloproliferative Neoplasms

INCA033989

(no location specified)

Sep 11, 2023

Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

Recruiting

Myeloproliferative Neoplasms

INCA033989
Ruxolitinib

Herston, Queensland, Australia
+22 more

Jun 30, 2023